α-Amylase in Vaginal Fluid: Association with Conditions Favorable to Dominance of Lactobacillus

Reproductive Sciences

Volumn 22, Issue 11, 2015, Pages 1393-1398

  Nasioudis, Dimitrios ^a   Beghini, Joziani ^a,b   Bongiovanni, Ann Marie ^a   Giraldo, Paulo C ^b   Linhares, Iara M ^c   Witkin, Steven S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

bacterial vaginosis; lactic acid; Lactobacilli; vaginal fluid; vulvovaginal candidiasis; amylase

Indexed keywords

AMYLASE; BETA DEFENSIN; ELAFIN; GLYCOGEN; HYALURONIC ACID; HYALURONIDASE; HYALURONIDASE 1; LACTIC ACID; NEUTROPHIL COLLAGENASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; HYALURONOGLUCOSAMINIDASE; LCN2 PROTEIN, HUMAN; LIPOCALIN; MMP8 PROTEIN, HUMAN; ONCOPROTEIN; SLPI PROTEIN, HUMAN;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HUMAN; ISOMER; LACTOBACILLUS; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL; SEXUALITY; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINITIS; CANDIDIASIS, VULVOVAGINAL; CASE CONTROL STUDY; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PH; SECRETION (PROCESS); VAGINA; VAGINOSIS, BACTERIAL; YOUNG ADULT;

ACUTE-PHASE PROTEINS; ADULT; ALPHA-AMYLASES; CANDIDIASIS, VULVOVAGINAL; CASE-CONTROL STUDIES; EPITHELIAL CELLS; FEMALE; GLYCOGEN; HUMANS; HYALURONOGLUCOSAMINIDASE; HYDROGEN-ION CONCENTRATION; LACTIC ACID; LACTOBACILLUS; LIPOCALIN-2; LIPOCALINS; MATRIX METALLOPROTEINASE 8; PROTO-ONCOGENE PROTEINS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; VAGINA; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 84943760998     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719115581000     Document Type: Article

References (35)

1. Zakowski JJ, Bruns DE,. Biochemistry of human alpha amylase isoenzymes. Crit Rev Clin Lab Sci. 1985; 21 (4): 283-322.
2. Lee YS, Raju GC,. The expression and localization of amylase in normal and malignant glands of the endometrium and endocervix. J Pathol. 1988; 155 (3): 201-205.
3. Skude G, Mårdh PA, Weström L,. Amylases of the genital tract. I. Isoamylases of genital tract tissue homogenates and peritoneal fluid. Am J Obstet Gynecol. 1976; 126 (6): 652-656.
4. Spear GT, French AL, Gilbert D, et al. Human α-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus. J Infect Dis. 2014; 210 (7): 1019-1028.
5. Boris S, Barbés C,. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect. 2000; 2 (5): 543-546.
6. Boskey ER, Cone RA, Whaley KJ, Moench TR,. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod. 2001; 16 (9): 1809-1813.
7. Linhares IM, Summers PR, Larsen B, Giraldo PC, Witkin SS,. Contemporary perspectives on vaginal pH and lactobacilli. Am J Obstet Gynecol. 2011; 204 (2): 120.e1-5.
8. Cruickshank R,. The biology of the vagina in the human subject. II: The bacterial flora and secretion of the vagina in relation to glycogen in the vaginal epithelium. J Obstet Gynecol Br Emp. 1934; 41 (2): 208-226.
9. Mirmonsef P, Hotton AL, Gilbert D, et al. Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH. PLoS One. 2014; 9 (7): e102467.
10. Mitchell C, Marrazzo J,. Bacterial vaginosis and the cervicovaginal immune response. Am J Reprod Immunol. 2014; 71 (6): 555-563.
11. Sobel JD,. Vulvovaginal candidosis. Lancet. 2007; 369 (9577): 1961-1971.
12. Zhou X, Westman R, Hickey R, et al. Vaginal microbiota of women with frequent vulvovaginal candidiasis. Infect Immun. 2009; 77 (9): 4130-4135.
13. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK,. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983; 74 (1): 14-22.
14. Nugent RP, Krohn MA, Hillier SL,. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991; 29 (2): 297-301.
15. Beghini J, Linhares I, Giraldo P, Ledger W, Witkin S,. Differential expression of lactic acid isomers, extracellular matrix metalloproteinase inducer, and matrix metalloproteinase-8 in vaginal fluid from women with vaginal disorders [published online September 8, 2014]. BJOG. 2014. doi: 10.1111/1471-0528.13072.
16. Beghini J, Giraldo PC, Linhares IM, Ledger WJ, Witkin SS,. Regulation of neutrophil gelatinase-associated lipocalin in vaginal fluid: relation to pathogenesis [published online February 10, 2015]. Reprod Sci. 2015.
17. Witkin SS, Mendes-Soares H, Linhares IM, et al. Influence of vaginal bacteria and d-and l-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. MBio. 2013; 4 (4): e00460-13.
18. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA,. Acid production by vaginal flora in vitro is consistent with the ratio and extent of vaginal acidification. Infect Immun. 1999; 67 (10): 5170-5175.
19. Hillier SL,. Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol. 1993; 169 (2 Pt 2): 455-459.
20. Iacono KT, Brown AL, Greene MI, Saouaf SJ,. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol. 2007; 83 (3): 283-295.
21. Rampersaud R, Planet PJ, Randis TM, et al. Interolysin, a cholesterol-dependent cytolysin produced by Lactobacillus iners. J Bacteriol. 2011; 193 (5): 1034-1041.
22. Simpson MA, Lokeshwar VB,. Hyaluronan and hyaluronidase in genitourinary tumors. Front Biosci. 2008; 13: 5664-5680.
23. Cooper MD, Roberts MH, Barauskas OL, Jarvis GA,. Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal. Am J Reprod Immunol. 2012; 68 (2): 116-127.
24. Wiesner J, Vilcinskas A,. Antimicrobial peptides: the ancient arm of the human immune system. Virulence. 2010; 1 (5): 440-464.
25. Balkus J, Agnew K, Lawler R, Mitchell C, Hitti J,. Effects of pregnancy and bacterial vaginosis on proinflammatory cytokine and secretory leukocyte protease inhibitor concentrations in vaginal secretions. J Pregnancy. 2010; 2010: 385981.
26. Mitchell C, Balkus J, Agnew K, Lawler R, Hitti J,. Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy. J Womens Health. 2009; 18 (11): 1817-1824.
27. Draper DL, Landers DV, Krohn MA, Hillier SL, Wiesenfeld HC, Heine RP,. Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol. 2000; 183 (5): 1243-1248.
28. Nikolaitchouk N, Andersch B, Falsen E, Strömbeck L, Mattsby-Baltzer I,. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH). APMIS. 2008; 116 (4): 263-277.
29. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK,. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002; 10 (5): 1033-1043.
30. Jarosik GP, Land CB, Duhon P, Chandler R Jr, Mercer T,. Acquisition of iron by Gardnerella vaginalis. Infect Immun. 1998; 66 (10): 5041-5047.
31. Imbert M, Blondeau R,. On the iron requirement of lactobacilli grown in chemically defined medium. Curr Microbiol. 1998; 37 (1): 64-66.
32. Elli M, Zink R, Rytz A, Reniero R, Morelli L,. Iron requirement of lactobacillus spp. in completely chemically defined growth media. J Appl Microbiol. 2000; 88 (4): 695-703.
33. Pivarcsi A, Nagy I, Koreck A, et al. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human beta-defensin-2 in vaginal epithelial cells. Microbs Infect. 2005; 7 (9-10): 1117-1127.
34. Curvelo JA, Barreto AL, Portela MB, et al. Effect of the secretory leukocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative? Arch Oral Biol. 2014; 59 (9): 928-937.
35. Feng Z, Jiang B, Chandra J, Ghannoum M, Nelson S, Weinberg A,. Human beta-defensins: differential activeity against candida species and regulation by Candida albicans. J Dent Res. 2005; 84 (5): 445-450.